The Latest: On January 18 2024, AstraZeneca, Lonza, Novartis, Novo Nordisk and Roche signed a three-year deal to purchase renewable...

Key View Australia-Mainland China relations have improved as both nations rekindle their trade ties.However, there is limited scope for ties to...

Key View: Despite a forecasted deceleration, we hold a positive outlook for consumer spending in Hong Kong, China over 2024. As...

Latest Development: Reportedly, Axiata Group is exploring options to sell part or all of its interest in Indonesian broadband and...

Latest Development: On January 22 2024, major pharmaceutical companies, including Roche and Sinopharm, have ramped up production in response to a...

Key ViewThe Monetary Authority of Singapore left policy settings unchanged at its January meeting.We expect the central bank to stand...

Key View: We believe that local and national governments will move to support the development of Vietnam's passenger EV-focused charging network...

Asia will face another challenging year in 2024. A likely global slowdown will cap growth recoveries in the region. Mainland...